Apyx Medical Corporation Announces Approval from FDA to Begin Phase II of US IDE Study

Retrieved on: 2020-11-23 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Apyx Medical Corporation Announces Approval from FDA to Begin Phase II of US IDE Study. View article details on hiswai:

Excerpt

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of <b>medical devices and</b> supplies and ...

Article found on: www.businesswire.com